FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Shilpa Medicare Pemrydi Rtu Recall

PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only…

Shilpa Medicare Limited

Risk level
Class II
Reported by FDA
Aug 26, 2026
Recall ID
D-0764-2026
Check your lot numberHow we source this data

Summary

Shilpa Medicare recalled Pemrydi Rtu starting Jul 29, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0764-2026 on Aug 26, 2026. Reason: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials. Status: Ongoing.

Why it was recalled

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Product description

PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1

Lot numbers, UPCs & expiration codes

Lot: P400172; Lot PA00050A, Exp 09/30/2027

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0764-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 29, 2026
FDA report date
Aug 26, 2026
Quantity
18,434 10mL vials
Recall type
Voluntary: Firm initiated
Recalling firm
Shilpa Medicare Limited

Original FDA data

Every field from FDA enforcement report D-0764-2026, exactly as published.

Show all FDA fields
City
Jadcherla, Mahabubnagar District
Status
Ongoing
Country
India
Event ID
99530
Address
Plot No. S20 to S26, Pharmaceutical Formulations SEZ
Address (line 2)
TSIIC Green Industrial Park, Polepally (Village)
Code information
Lot: P400172; Lot PA00050A, Exp 09/30/2027
Report date
Aug 26, 2026
Product type
Drugs
Recall number
D-0764-2026
Classification
Class II
Recalling firm
Shilpa Medicare Limited
Product quantity
18,434 10mL vials
Reason for recall
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Voluntary / mandated
Voluntary: Firm initiated
Product description
PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jul 29, 2026
Initial firm notification
Letter
Center classification date
Aug 14, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0764-2026, published Aug 26, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls